MeSH Review:
Immunization Schedule
- Effect of dose and immunization schedule on immune response of baboons to recombinant glycoprotein 120 of HIV-1. Anderson, K.P., Lucas, C., Hanson, C.V., Londe, H.F., Izu, A., Gregory, T., Ammann, A., Berman, P.W., Eichberg, J.W. J. Infect. Dis. (1989)
- Susceptibility to and escape from complement-mediated lysis of guinea-pig hepatoma line-10. Abe, S., Berczi, I., Sehon, A.H. Int. J. Cancer (1977)
- Coronavirus-induced encephalomyelitis: balance between protection and immune pathology depends on the immunization schedule with spike protein S. Flory, E., Stühler, A., Barac-Latas, V., Lassmann, H., Wege, H. J. Gen. Virol. (1995)
- Anaphylactic bronchoconstriction in rats immunized with antigen-coated latex particles. Eady, R.P., Trigg, S., Orr, T.S. Clin. Exp. Immunol. (1978)
- The efficacy of DPT and oral poliomyelitis immunization schedules initiated from birth to 12 weeks of age. Halsey, N., Galazka, A. Bull. World Health Organ. (1985)
- Oral immunization with hepatitis B surface antigen expressed in transgenic plants. Kong, Q., Richter, L., Yang, Y.F., Arntzen, C.J., Mason, H.S., Thanavala, Y. Proc. Natl. Acad. Sci. U.S.A. (2001)
- Effect of thymopoietin pentapeptide (TP5) on autoimmunity. I. TP5 suppression of induced erythrocyte autoantibodies in C3H mice. Lau, C.Y., Freestone, J.A., Goldstein, G. J. Immunol. (1980)
- Interleukin-12 (IL-12) enhancement of the cellular immune response against human immunodeficiency virus type 1 env antigen in a DNA prime/vaccinia virus boost vaccine regimen is time and dose dependent: suppressive effects of IL-12 boost are mediated by nitric oxide. Gherardi, M.M., Ramírez, J.C., Esteban, M. J. Virol. (2000)
- DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies. Hosie, M.J., Flynn, J.N., Rigby, M.A., Cannon, C., Dunsford, T., Mackay, N.A., Argyle, D., Willett, B.J., Miyazawa, T., Onions, D.E., Jarrett, O., Neil, J.C. J. Virol. (1998)
- Inactivated poliovirus vaccine protects transgenic poliovirus receptor mice against type 3 poliovirus challenge. Taffs, R.E., Chernokhvostova, Y.V., Dragunsky, E.M., Nomura, T., Hioki, K., Beuvery, E.C., Fitzgerald, E.A., Levenbook, I.S., Asher, D.M. J. Infect. Dis. (1997)
- Luteinizing hormone-releasing hormone fusion protein vaccines block estrous cycle activity in beef heifers. Stevens, J.D., Sosa, J.M., deAvila, D.M., Oatley, J.M., Bertrand, K.P., Gaskins, C.T., Reeves, J.J. J. Anim. Sci. (2005)
- Induction of humoral immunity toward 2-acetylaminofluorene in mice: modulation of DNA binding after 4 weeks dietary exposure to the carcinogen. Verdina, A., Zito, R., Cortese, G., Leopardi, P., Marcon, F., Zijno, A., Crebelli, R. Carcinogenesis (1996)
- Suppression of local intestinal immunoglobulin A immune response to cholera toxin by subcutaneous administration of cholera toxoids. Hamilton, S.R., Yardley, J.H., Brown, G.D. Infect. Immun. (1979)
- In vivo cimetidine immunomodulatory effects on the cutaneous reaction to oxazolone in the chicken. Bellavia, A., Bannera, A.F., Marino, V., Arcoleo, V., Ferrara, D. Immunopharmacology (1997)
- Immunogenicity of a polyvalent melanoma antigen vaccine in humans. Bystryn, J.C., Oratz, R., Harris, M.N., Roses, D.F., Golomb, F.M., Speyer, J.L. Cancer (1988)
- Studies on the optimal immunization schedule of experimental animals. VI. Antigen dose-response of aluminum hydroxide-aided immunization and booster effect under low antigen dose. Hu, J.G., Kitagawa, T. Chem. Pharm. Bull. (1990)
- A new look at measles. Adcock, L.M., Bissey, J.D., Feigin, R.D. Infect. Dis. Clin. North Am. (1992)
- The role of somatic structure of the fungus Paracoccidioides brasiliensis upon B cell activation in experimental paracoccidioidomycosis. Silva, M.F., Silva, C.L. Clin. Exp. Immunol. (1995)
- Immunogenicity of Nef protein of SIVSMM-PBj14 expressed in a live vaccine strain of Salmonella species. Cattozzo, E.M., Stocker, B.A. AIDS Res. Hum. Retroviruses (1994)
- Stochastic humoral expression of human growth hormone epitopes. Etcheverrigaray, M., Paladini, A.C., Retegui, L.A. Immunology (1988)
- Mycobacterial cord factor, but not sulfolipid, causes depletion of NKT cells and upregulation of CD1d1 on murine macrophages. Ryll, R., Watanabe, K., Fujiwara, N., Takimoto, H., Hasunuma, R., Kumazawa, Y., Okada, M., Yano, I. Microbes Infect. (2001)
- Impaired antibody response rates after high dose short interval hepatitis B virus vaccination of immunosuppressed individuals. Idilman, R., Colantoni, A., De Maria, N., Ustun, C., Sam, R., Ing, T.S., Akan, H., Koc, H., Van Thiel, D.H. Hepatogastroenterology (2003)
- The hepatitis B immunization campaign for children in the Federated States of Micronesia. Manea, S.J., Iohp, K. Public health reports (Washington, D.C. : 1974) (1992)